Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce E Torbett

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Molecular Therapy. Nucleic Acids|November 29, 2019
Development of Lentiviral Vectors for HIV-1 Gene Therapy with Vif-Resistant APOBEC3GKrista A Delviks-Frankenberry, Daniel Ackerman, Nina D Timberlake, et al.
British Journal of Haematology|March 6, 2008
HIC1 tumour suppressor gene is suppressed in acute myeloid leukaemia and induced during granulocytic differentiationChristian Britschgi, Mathias Jenal, Mattia Rizzi, et al.
British Journal of Haematology|December 21, 2012
The actin-binding protein CORO1A is a novel PU.1 (SPI1)- and CEBPA-regulated gene with significantly lower expression in APL and CEBPA-mutated AML patientsElena A Federzoni, Magali Humbert, Peter J M Valk, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 26, 2012
Zinc-finger nuclease editing of human cxcr4 promotes HIV-1 CD4(+) T cell resistance and enrichmentJinyun Yuan, Jianbin Wang, Karen Crain, et al.
Stem Cells (Dayton, Ohio)|December 20, 2014
Safety and efficacy of a tCD25 preselective combination anti-HIV lentiviral vector in human hematopoietic stem and progenitor cellsSharlie L Barclay, Yimin Yang, Siruo Zhang, et al.
Retrovirology|November 24, 2004
Assessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3Sohela de Rozières, Christina H Swan, Dennis A Sheeter, et al.
Journal of Molecular Biology|April 8, 2020
Sequencing and Structure Probing of Long RNAs Using MarathonRT: A Next-Generation Reverse TranscriptaseLi-Tao Guo, Rebecca L Adams, Han Wan, et al.
Journal of Medicinal Chemistry|October 1, 2008
A copper(I)-catalyzed 1,2,3-triazole azide-alkyne click compound is a potent inhibitor of a multidrug-resistant HIV-1 protease variantMichael J Giffin, Holly Heaslet, Ashraf Brik, et al.
Biorxiv : the Preprint Server for Biology|March 23, 2026
Lenacapavir prevents production of infectious HIV-1 by abrogating immature virus assemblyClifton L Ricaña, Savannah G Brancato, Carolyn M Highland, et al.
Journal of Molecular Biology|February 4, 2021
Discrimination between Functional and Non-functional Cellular Gag Complexes involved in HIV-1 AssemblyYisong Deng, John A Hammond, Raymond Pauszek, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Molecular Therapy. Nucleic Acids|November 29, 2019
Development of Lentiviral Vectors for HIV-1 Gene Therapy with Vif-Resistant APOBEC3GKrista A Delviks-Frankenberry, Daniel Ackerman, Nina D Timberlake, et al.
British Journal of Haematology|March 6, 2008
HIC1 tumour suppressor gene is suppressed in acute myeloid leukaemia and induced during granulocytic differentiationChristian Britschgi, Mathias Jenal, Mattia Rizzi, et al.
British Journal of Haematology|December 21, 2012
The actin-binding protein CORO1A is a novel PU.1 (SPI1)- and CEBPA-regulated gene with significantly lower expression in APL and CEBPA-mutated AML patientsElena A Federzoni, Magali Humbert, Peter J M Valk, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 26, 2012
Zinc-finger nuclease editing of human cxcr4 promotes HIV-1 CD4(+) T cell resistance and enrichmentJinyun Yuan, Jianbin Wang, Karen Crain, et al.
Stem Cells (Dayton, Ohio)|December 20, 2014
Safety and efficacy of a tCD25 preselective combination anti-HIV lentiviral vector in human hematopoietic stem and progenitor cellsSharlie L Barclay, Yimin Yang, Siruo Zhang, et al.
Retrovirology|November 24, 2004
Assessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3Sohela de Rozières, Christina H Swan, Dennis A Sheeter, et al.
Journal of Molecular Biology|April 8, 2020
Sequencing and Structure Probing of Long RNAs Using MarathonRT: A Next-Generation Reverse TranscriptaseLi-Tao Guo, Rebecca L Adams, Han Wan, et al.
Journal of Medicinal Chemistry|October 1, 2008
A copper(I)-catalyzed 1,2,3-triazole azide-alkyne click compound is a potent inhibitor of a multidrug-resistant HIV-1 protease variantMichael J Giffin, Holly Heaslet, Ashraf Brik, et al.
Biorxiv : the Preprint Server for Biology|March 23, 2026
Lenacapavir prevents production of infectious HIV-1 by abrogating immature virus assemblyClifton L Ricaña, Savannah G Brancato, Carolyn M Highland, et al.
Journal of Molecular Biology|February 4, 2021
Discrimination between Functional and Non-functional Cellular Gag Complexes involved in HIV-1 AssemblyYisong Deng, John A Hammond, Raymond Pauszek, et al.
Pageof 11